Skip to the page

Data / Form D filings / LAM PHARMACEUTICAL CORP

LAM PHARMACEUTICAL CORP: Form D filing

LAM PHARMACEUTICAL CORP, a pharmaceuticals company in Toronto, Ontario, Canada, filed a Form D with the SEC in 2013. The latest, on October 24, 2013, reports $172,000 sold of a $1 million offering to 1 investor.

Find out what LAM PHARMACEUTICAL CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
425 University Av. Suite 601, Toronto, Ontario, Canada, M5G1T
Phone
(416) 619-0291
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
No Revenues
Exemptions claimed
Rule 504, Rule 504(b)(1)(i), Rule 504(b)(1)(ii), Rule 504(b)(1)(iii)
SEC identifier (CIK)
1071272

The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 24, 2013New notice$1,000,000$172,000$828,0001Aug 1, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Pepe CarlaDirector
John AdamsExecutive Officer

Every Form D from the week of Oct 21, 2013 · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what LAM PHARMACEUTICAL CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.